NCT04916470: Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes
- State
- Completed
- Phase
- Phase 3
- People
- 617 taking part
- Started
- 15 Jun 2021
- Primary completion
- 11 Oct 2023
- Arms
- Semaglutide 2.4 mg once weekly (OW)
- Results
- Posted on the registry
- 7 Jun 2021: Trial registered
- 15 Jun 2021: Trial started
- 11 Oct 2023: Trial completed
- 2 Nov 2026: Trial results posted